SCHEMBL1961849

SCHEMBL1961849

CC(c1ccccc1)C1CNCCO1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 15/20 0.57
SLC6A4 P31645 15/20 0.57
SLC6A3 Q01959 11/20 0.57
MLNR O43193 1/20 0.53
ADRB2 P07550 1/20 0.53
CHRM2 P08172 1/20 0.53
CHRM1 P11229 1/20 0.53
CHRM3 P20309 1/20 0.53
HTR2C P28335 1/20 0.53
OPRK1 P41145 1/20 0.53
KCNH2 Q12809 1/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
MAPK1 P28482 1/20 0.53
KMT2A Q03164 1/20 0.53
HRH1 P35367 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4631199 1.00 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL6540781 0.86 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL28775877 0.85 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL6978722 0.84 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27790028 0.84 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27989307 0.81 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL28352387 0.81 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL27781287 0.80 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL4595727 0.80 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3MLNRADRB2
SCHEMBL4596454 0.80 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3MLNRADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104066787-B Conductive poly acetal resin composition and formed body 旭化成株式会社 2018-12-25 CN disclosed
CN-104903320-B Nitrogen-containing heterocycle compound or its salt 富士胶片株式会社 2018-11-13 CN disclosed
EP-2513028-B1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, USE OF SAID ALIZARIN COMPOUND, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR FUJIFILM CORP (JP) 2018-06-20 EP disclosed
CN-102639480-B Method for producing alizarin derivative compound, novel alizarin derivative compound, surface modification method, photoelectric conversion film, photoelectric conversion element, and electrophotographic photoreceptor FUJIFILM CORP. (JP) 2015-10-07 CN disclosed
CN-104812835-A Polyacetal resin composition and molded body molded therefrom ASAHI KASEI CHEMICALS CORP 2015-07-29 CN disclosed
CN-104066787-A Electroconductive polyacetal resin composition and molded article ASAHI KASEI CHEMICALS CORP 2014-09-24 CN disclosed
CN-103881288-A Conductive polyacetal resin composition particle and formed member thereof ASAHI KASEI CHEMICALS CORP 2014-06-25 CN disclosed
US-8741513-B2 Method for preparing alizarin derivative compound, novel alizarin derivative compound, surface modification method, photoelectric conversion film, photoelectric conversion element, and electrophotographic photoreceptor FUJIFILM CORPORATION (JP) 2014-06-03 US disclosed
EP-2513028-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR FUJIFILM Corporation (JP) 2012-10-24 EP disclosed
US-20120244462-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR FUJIFILM CORPORATION (JP) 2012-09-27 US disclosed
CN-102639480-A Method for producing alizarin derivative compound, novel alizarin derivative compound, surface modification method, photoelectric conversion film, photoelectric conversion element, and electrophotographic photoreceptor FUJIFILM CORP 2012-08-15 CN disclosed
WO-2011071130-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR FUJIFILM CORPORATION (JP) 2011-06-16 WO disclosed
WO-2009010373-A1 METHOD FOR REMOVING ACIDS FROM (METH)ACRYLIC ACID ESTERS BY FILTERING ADSORPTION ON A POWDERY ADSORPTION AGENT BASF SE (DE) 2009-01-22 WO disclosed
EP-2017256-A1 Method for removing acids from (meth) acrylic acid esters using filtering adsorption by a power-like adsorption agent BASF SE (DE) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120244462-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR NR2E3, INA, NHERF1 SLC6A2 2130/4885SLC6A4 2501/4885SLC6A3 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.